Access to Services in Prison and Beyond

Slides:



Advertisements
Similar presentations
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Advertisements

Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.
Strategies and Interventions for Community-Based Organizations Implementing HIV Prevention Joseph Prejean, Ph. D. Capacity Building Branch Division of.
Integration of Viral Hepatitis Prevention with STD Prevention: What Health Professionals Should Know Presenter: Jay Todd, Training and Public Education.
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
Operational Approaches for Comprehensive Sex Worker Programmes An overview of Implementing Comprehensive HIV/STI Programmes with Sex Workers: Practical.
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
HIV AIDS Section Fabienne Hariga Senior Adviser UNODC HIV AIDS section, Vienna Comprehensive package of interventions for HIV in prison settings AIDS 2012.
Midwest AIDS Training & Education Center Health Care Education & Training, Inc. HIV/AIDS Case-Finding In Family Planning Clinics.
HIV and drug prevention in Estonia Harm reduction services
Dilemmas in the treatment of HIV and Hepatitis C in Canadian prisons.
Comprehensive HIV Prevention Strategies for Most at Risk Populations (MARPs) Anne Goldzier Thomas, Ph.D. US Department of Defense/PEPFAR Ethiopia National.
Results from the Spanish experience: A comprehensive approach to HIV and HCV in prisons MERCEDES GALLIZO LLAMAS Secretary-General of Spanish Prison Administration.
HIV/AIDS BI-ANNUAL REVIEW 2008 Prevention -Goal, Indicators and Targets TACAIDS.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
Resource Needs Model Rachel Sanders October 28 th, 2010.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) Session: Voluntary Medical Male Circumcision (VMMC)
Project RAS/H13 “Prevention of transmission of HIV among drug users in SAARC Countries” Lubna Mohamed Zahir Hussain Chairperson of National Drug Agency.
Harm Reduction International
President’s Emergency Plan for AIDS Relief 2006 Semi-Annual Program Results (SAPR) October 1, 2005 – March 31, 2006.
HIV/AIDS, Housing and Risk Behaviors CT AIDS Resource Coalition and CIRA Community Research Partnership Program.
Knowing your Epidemic: Designing Better Interventions in Prisons Deputy Commissioner Mary C. Chepkonga Kenya Prisons Service International AIDS Conference.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
4 th AMTP UA Progress Report 5 th AMTP Outcomes Framework VISION The spread of HIV is halted in the Philippines OUTCOMES Persons at-risk, vulnerable,
New Prevention Technologies Workshop Module 2: NPTs in context
The Canadian Correctional Public Health Program Prison Health Expert Group Sixth Meeting Oslo, Norway September 30, 2008.
Results from the STEAM Survey Elizabeth Barash, MPH.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Abstract #TUPDE202: Collaboration and Cross Training between Health and Correctional Services Leads to More Integrated Services for PHAs in Prison: Poster.
Thematic Priorities for ATF Applications Presentation by Secretariat of Council for the AIDS Trust Fund in Briefing Session on 27 July
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
State Office of AIDS Update
IAS Satellite Session 25th July 2017 Daniel Were, PhD
PrEP for HIV Prevention
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people: Annual Surveillance Report 2016.
Fabienne Hariga Senior Adviser, HIV/AIDS Section
HIV Burden Among Gay and Bisexual Men in the U.S.
TransIT The Transgender Implementation Tool for the WHO key population guidelines.
Treatment Outcomes for Chronic Hepatitis C Infection with Direct Acting Antivirals among Inmates in Federal Corrections Smith JM, Boudreau H, Kom E, Tremblay.
Government of Swaziland
Pakistan Last updated: July 2015.
Andy Mills Manager Complex Needs Team
WHO minimum public health data set on prison health
Rowe, KA1, Tesoriero, JM1, Davis, SJ1, Heavner, KK1, Rothman, J2,
Reitox National Focal Point National Bureau for Drug Prevention
Viral Hepatitis in Correctional Settings
People who inject drugs
Time to Focus: Doing Things Better and Differently for Transgender People Rena Janamnuaysook Thai Red Cross AIDS Research Centre, USAID LINKAGES, Thailand.
One pill a day, can keep HIV away
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Overview of importance and emerging innovations for testing and linkage CHERYL JOHNSON WORLD HEALTH ORGANIZATION HIV AND HEPATITIS DEPARTMENT 23 JULY.
Preliminary Draft 5 Year Action Plan HIV, Hepatitis C, and STIs
Edward Mbizo Sibanda, (MSc) Right to Care
National Department of Health: South Africa
BBV & STIs in Victorian Prisons
Progress in Facilitating National HCV Prevention
HIV.
Human Dignity and Harm Reduction
Managing Hepatitis C in Vermont
Share your thoughts on this presentation with #IAS2019
March 8, 2006 New ACIP Hepatitis B Recommendations
Presentation transcript:

Access to Services in Prison and Beyond Jennifer Wheatley, Assistant Commissioner Health Services Health Services Sector, Correctional Services Canada

Background Correctional Services Canada(CSC) is: Responsible for administering court-imposed sentences of 2 years or more for adult offenders Mandated under the Corrections and Conditional Release Act (CCRA) to provide all essential health care and access to non-essential mental health services that conforms to professionally accepted standards Responsible for the safety and security of both staff and offenders and are key priorities for CSC Responsible for the management of 43 institutions in 5 regions including institutional health care units, regional mental health treatment centres and regional hospitals Responsible for 14, 300 offenders in custody of which 95% are male and 5% female1 1Source: CSC Departmental Performance Report, 2016-2017, http://www.csc-scc.gc.ca/publications/005007-4500-2016-2017-en.shtml) #AIDS2018 | @AIDS_conference | www.aids2018.org

Background #AIDS2018 | @AIDS_conference | www.aids2018.org

Background Injection Drug Use There are a number of published reports that give consistent estimates of injection drug use prior to incarceration at CSC: 22% of men and 29% of women reported a lifetime history of injection drug use (anonymous survey)1; 21% of men reported a history of injection drug use on a standardized intake assessment instrument2,3; Studies based on the self-reported health status of federally sentenced offenders at intake found that 21% of men and 27% of women reported ever-having injected drugs4; Data from 2007 found that 17% of inmates reported injecting drugs (at least once) in the past 6 months1 1- Research Report: Emerging Findings from the Inmate Survey” April 2010; 2 - Research Snippet “Prevalence of Injection Drug Use among Male Offenders”. October 2010, Number 10-2; 3 - Research in Brief “Lifetime Substance Use Patterns of Men Offenders”, February 2015, Number 14-43; 4 - Emerging Research Results “Self-Reported Physical Health Status of Incoming Federally-Sentenced Women Offenders: Comparison to Men Offenders”, March 2014, Number 14-5 #AIDS2018 | @AIDS_conference | www.aids2018.org

HIV / HCV Prevention and Treatment CSC has policies and programs that support all 15 of UNODC recommendations for HIV prevention, including HIV / HCV screening and testing on admission and throughout incarceration Access to counselling and medical treatment Pre-Exposure Prophylaxis (PrEP) Health promotion and peer support programs Access to harm reduction (condoms, dental dams, bleach) Opiate Substitution Therapy (OST) Nasal naloxone Take-home Naloxone program at release Prison Needle Exchange Program (PNEP) #AIDS2018 | @AIDS_conference | www.aids2018.org

HIV in CSC The prevalence of HIV among CSC inmates has declined from 2.02% in 2007 to 1.19% in 2014 and 1.28% in 2016 (http://www.csc-scc.gc.ca/publications/005007-3035-eng.shtml) Through the Government of Canada, CSC supports UNAIDS HIV ‘‘treatment as prevention’’ targets of ‘‘90-90-90’’ by the year 2020. Preliminary results for CSC in 2016–2017 indicate that: - 96% of newly admitted offenders to CSC accepted a voluntary blood test for HIV; - 94% of inmates known to be living with HIV were on HIV treatment; and - 91% of inmates on HIV treatment demonstrated viral suppression at follow-up (https://www.canada.ca/en/public- health/services/publications/diseases- conditions/backgrounder-progress-90-90-90-hiv- targets.html) #AIDS2018 | @AIDS_conference | www.aids2018.org

HEPATITIS C VIRUS CSC’s proactive ‘‘treatment as prevention’’ approach with all-oral anti-hepatitis C medications (doubled from 300 in 2015–2016 to over 600 in 2016–2017) has contributed to a 50% decline in HCV prevalence from 18% in 2014 to 7.7% in 2016. (http://www.csc-scc.gc.ca/publications/005007-3038-eng.shtml) #AIDS2018 | @AIDS_conference | www.aids2018.org

Pre-Exposure Prophylaxis (PrEP) Pre-exposure Prophylaxis (PrEP) is available to inmates at high-risk of HIV acquisition Sexual transmission of HIV (including MSM, sero-discordant partners, and sex work) Injection drug use Inmates are assessed for HIV risk by institutional physician Agree to baseline testing and follow up Formal program launched July 2018 NOTE: post-exposure prophylaxis (PEP) is also available for inmates References: CATIE; CDC; Government of Canada; Justin Sullivan via Getty Images #AIDS2018 | @AIDS_conference | www.aids2018.org

Health Promotion Health Promotion and Harm Reduction information at admission Inmate fact sheets on a wide number of health topics Peer support programs in place Mental Health Workshops Anti HIV-stigma campaigns Inmate television and inmate library #AIDS2018 | @AIDS_conference | www.aids2018.org

Harm Reduction Condom/dental damn and lubricant distribution Bleach distribution Nasal naloxone (correctional officers) Take-home Naloxone program at release #AIDS2018 | @AIDS_conference | www.aids2018.org

Opiate Substitution Therapy Drug Counselling & Treatment Offenders may participate in Narcotics Anonymous (NA) during incarceration (inreach or outreach) Access to counselling from Mental Health Services Access to Opioid Substitution Therapy (OST) since 2001 Implementing Suboxone® film and injectable buprenorphine (Fall 2018) 25% increase in the number of inmates on OST since Oct 2016 > 1000 inmates were on OST Dec. 2017 #AIDS2018 | @AIDS_conference | www.aids2018.org

Prison-based Needle Exchange Program (PNEP) PNEP is a Health Services Harm reduction program consistent with Government of Canada Canadian Drug and Substance Strategy (CDSS) ARE YOU AT RISK ? Do you inject drugs and share needles or rigs? Do you re-use a cooker or a spoon when injecting drugs? PNEP launched June 2018 as a phased-in approach at one female institution in the Ontario Region and one male institution in Atlantic Region Objectives are to reduce rigs and needle sharing, reduce skin-soft tissue infection (SSTI), reduce HIV / HCV transmission, promote referral to counselling and addictions treatment #AIDS2018 | @AIDS_conference | www.aids2018.org